Myeloma protein: Difference between revisions
CSV import |
CSV import |
||
| Line 45: | Line 45: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Monoclonal gammopathy Multiple Myeloma.png|Myeloma protein | |||
</gallery> | |||
Latest revision as of 01:37, 20 February 2025
Myeloma Protein
Myeloma protein is a type of protein produced by plasma cells in the bone marrow. It is associated with a group of diseases known as monoclonal gammopathies, which include multiple myeloma, Waldenström's macroglobulinemia, and other related conditions.
Overview[edit]
Myeloma proteins are abnormal proteins that are produced in excess by malignant plasma cells. These proteins can be detected in the blood and urine of individuals with monoclonal gammopathies. The presence of myeloma proteins can cause a variety of symptoms and complications, including anemia, bone pain, kidney damage, and increased susceptibility to infections.
Types of Myeloma Proteins[edit]
There are several types of myeloma proteins, including:
- Immunoglobulin G (IgG): This is the most common type of myeloma protein. It is associated with multiple myeloma and other conditions.
- Immunoglobulin A (IgA): This type of myeloma protein is less common than IgG, but it is also associated with multiple myeloma.
- Immunoglobulin M (IgM): This type of myeloma protein is associated with Waldenström's macroglobulinemia.
- Light chains: These are smaller proteins that are part of the larger immunoglobulin molecules. They can be produced in excess in some types of monoclonal gammopathies.
Diagnosis[edit]
The presence of myeloma proteins can be detected through a variety of laboratory tests, including:
- Serum protein electrophoresis (SPEP): This test separates proteins in the blood based on their electrical charge. It can detect the presence of abnormal proteins.
- Urine protein electrophoresis (UPEP): This test is similar to SPEP, but it is used to detect proteins in the urine.
- Immunofixation: This test is used to identify the specific type of myeloma protein present.
Treatment[edit]
Treatment for conditions associated with myeloma proteins typically involves addressing the underlying disease. This may include chemotherapy, stem cell transplantation, and other treatments.
